Details of the Drug

General Information of Drug (ID: DM0TD4G)

• Drug Name: NanoPac

Indication

Disease Entry	ICD 11	Status	REF
Actinic keratosis	EK90.0	Phase 2	[1]
Ovarian cancer	2C73	Phase 2	[2]
Prostate cancer	2C82.0	Phase 2	[2]
Skin metastasis	2D50	Phase 2	[1]

• Cross-matching ID: TTD ID: D0FZ7Q
• Repurposed Drugs (RPD): Click to Jump to the Detailed RPD Information of This Drug

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
• [2] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)